2023 annual financial data
Kazia Therapeutics 2023 Operating margin
Direct answer
Operating margin was -4,346,661.08%.
Operating income was -24,123,969 AUD and net income was -20,465,180 AUD.
Operating cash flow was -15,156,000 AUD.
Get free Kazia Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 555 AUD
- Operating income
- -24,123,969 AUD
- Net income
- -20,465,180 AUD
- Operating cash flow
- -15,156,000 AUD